Department of Industrial Biological Chemistry, University of Liege - Gembloux Agro-Bio Tech, Passage des D´eport´es, 2, B-5030 Gembloux, Belgium.
Crit Rev Food Sci Nutr. 2011 May;51(5):394-409. doi: 10.1080/10408391003628955.
This critical review article presents the current state of knowledge on isomalto-oligosaccharides, some well known functional oligosaccharides in Asia, to evaluate their potential as emergent prebiotics in the American and European functional food market. It includes first a unique inventory of the different families of compounds which have been considered as IMOs and their specific structure. A description has been given of the different production methods including the involved enzymes and their specific activities, the substrates, and the types of IMOs produced. Considering the structural complexity of IMO products, specific characterization methods are described, as well as purification methods which enable the body to get rid of digestible oligosaccharides. Finally, an extensive review of their techno-functional and nutritional properties enables placing IMOs inside the growing prebiotic market. This review is of particular interest considering that IMO commercialization in America and Europe is a topical subject due to the recent submission by Bioneutra Inc. (Canada) of a novel food file to the UK Food Standards Agency, as well as several patents for IMO production.
这篇评论文章介绍了异麦芽低聚糖(IMO)的最新研究进展,IMO 是亚洲广为人知的功能性低聚糖,本文评估了 IMO 作为新型益生元在美国和欧洲功能性食品市场的应用潜力。首先,文章对被认为是 IMO 的不同化合物家族及其特定结构进行了独特的分类。描述了不同的生产方法,包括涉及的酶及其特定活性、底物和产生的 IMO 类型。考虑到 IMO 产品的结构复杂性,本文还介绍了特定的特性描述方法和纯化方法,这些方法可以使人体摆脱可消化的低聚糖。最后,对其技术功能和营养特性的广泛回顾使 IMO 能够进入不断发展的益生元市场。考虑到 Bioneutra Inc.(加拿大)最近向英国食品标准局提交了一份新型食品文件,以及几项 IMO 生产专利,IMO 在美国和欧洲的商业化是一个热门话题,因此本文具有特别的参考意义。